Cargo-carrying red blood cells alleviate autoimmune diseases in mice

blood cells
Scanning electron micrograph of blood cells. From left to right: human erythrocyte, thrombocyte (platelet), leukocyte. Credit: public domain

Using red blood cells modified to carry disease-specific antigens, scientists in the laboratories of Hidde Ploegh (former Whitehead Member, currently Boston Children's Hospital) and Harvey Lodish (Whitehead Founding Member) have prevented and alleviated two autoimmune diseases—multiple sclerosis (MS) and type 1 diabetes—in early stage mouse models.

"This is a very promising step in the development of therapies for autoimmune diseases," says Lodish, who is also a professor of biology and a professor of at MIT. "If this type of response is also true in humans, then it could make a lot of these therapies possible for these diseases and similar conditions."

Inappropriate immune responses cause scores of autoimmune diseases—from rheumatoid arthritis to to inflammatory bowel disease—in which the body destroys its own cells. The National Institutes of Health estimates that autoimmune diseases affect more than 23 million Americans. These conditions are commonly treated with immunosuppressants to keep a patient's overactive immune response in check. However, these drugs also indiscriminately dull the immune response to pathogens.

Using bits of proteins from the offending cells—antigenic peptides—researchers have retrained the immune system to ignore the antigens that trigger inappropriate immune responses. This method, called tolerance induction, shows promise, but the technique is fraught with problems, including delivering the antigenic peptides to their destination before they are degraded or beset by .

To sidestep many of these issues, the labs of Lodish and Ploegh have pressed red into service.

Red blood cells are particularly well-suited for the delivery of molecules throughout the body. Not only do these cells quickly access almost every tissue, they are also recycled every month in mice and four months in humans without triggering an immune response against them. In previous research, the team attached biotin (a chemical tag) and antibodies to red blood cell using a method developed by Ploegh's lab called "sortagging".

The current work, which is described online this week in the journal PNAS, uses cargo-laden red blood cells to intercede in . Novalia Pishesha, an MIT Biological Engineering graduate student in the Lodish and Ploegh labs, drew blood from a mouse, used sortagging to decorate the red blood cells with the antigens that trigger the harmful , and transfused the altered red blood cells back into mouse models of type 1 diabetes and MS. The entire process can be completed in about an hour.

In mice, the transfusions reduced symptoms of disease and even a single injection prior to the onset of disease could prevent further symptoms.

Although antigenic peptides can be effective in stimulating the induction of tolerance, the mechanism responsible is not well understood at the cellular and molecular levels.. "Essentially what we're doing is hijacking the clearance pathway, such that the foreign antigen masquerades as the red blood cells' own, such that these antigens are being tolerated in the process," says Pishesha, who is also the first author of the PNAS paper.

For Ploegh, the research could lead to future insights into how the immune system regulates itself and how that sometimes goes awry. As a cautionary note, he points out that red blood cells used in the experiment are not "immunologically inert".

"The Kell protein, which we use as an anchor point for many of our modifications, is a blood group antigen, and by its very nature shows that the immune system can distinguish red blood cells from genetically disparate individuals," says Ploegh. "This [technique used by Pishesha] may be an interesting way to explore how the distinguishes self from non-self."


Explore further

Scientists identify factor that may trigger type 1 diabetes

More information: Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease, PNAS (2017). DOI: 10.1073/pnas.1701746114
Citation: Cargo-carrying red blood cells alleviate autoimmune diseases in mice (2017, March 6) retrieved 15 September 2019 from https://medicalxpress.com/news/2017-03-cargo-carrying-red-blood-cells-alleviate.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
534 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more